Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
12 April 2018
Answer given by President Juncker on behalf of the Commission
Question reference: P-000652/2018

Paragraph 15 of the Guidelines for Brexit negotiations of the European Council (Article 50) of 29 April 2017 states that ‘the future location of the seats of EU agencies and facilities located in the United Kingdom (UK) is a matter for the 27 Member States to settle rapidly’(1).

In the margins of the European Council (Article 50) of 22 June 2017, the 27 Member States endorsed the procedure leading up to a decision on the relocation of the UK-based agencies(2). The Commission was asked therein to examine the Member States' offers to host one or both of the agencies and to present its assessment that would serve to inform the process of the 27 Member States for the selection of the agencies' new seats.

For this purpose, the Commission was provided by the Secretary-General of the Council with both the public and the confidential versions of Member States’ offers.

The Commission’s methodology for assessing the Member States' offers within the specific mandate that was given to it by the 27 Member States is set out in its Note of 30 September 2017(3). Due to the limited time available to assess the offers and in order to treat all offers fairly, the Commission decided for its examination to rely solely on the offers as presented by the Member States and did not take any steps to verify the information provided in the offers. In order to put all offers on the same footing, the Commission did not ask Member States to clarify or complete their offers. The Commission’s assessment relies therefore on the accuracy and completeness of the information provided by the Member States in their offers.

The Government of the Netherlands has confirmed that it will cover the costs related to the temporary premises of the European Medicines Agency, including the move into the permanent premises. Consequently, the use of the temporary premises will have no impact on the EU budget. As regards the permanent building, on 2 March 2018 the agency presented a full building file to the Budgetary Authority, on the basis of Article 203 of the Financial Regulation. The building file was adopted by the Agency's management board on 28 February 2018.


Last updated: 13 April 2018Legal notice